SCHEMBL21298079

SCHEMBL21298079

N#Cc1cc2c3cc4ccccc4cc3c3nc(C#N)c(C#N)nc3c2cc1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 4/20 0.39
GAA P10253 3/20 0.39
NCOA3 Q9Y6Q9 1/20 0.36
HTT P42858 3/20 0.35
USP8 P40818 2/20 0.35
USP7 Q93009 2/20 0.35
USP47 Q96K76 1/20 0.35
LMNA P02545 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
THRB P10828 1/20 0.35
DYRK1A Q13627 2/20 0.34
CLK1 P49759 1/20 0.34
MEN1 O00255 3/20 0.33
HPGD P15428 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
NQO1 P15559 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21298013 0.93 USP8 (0.39) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL21298257 0.89 USP8 (0.39) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL13205968 0.89 ALDH1A1 (0.38) ALDH1A1KDM4ENCOA3HTTLMNA
SCHEMBL21298354 0.87 ALDH1A1 (0.37) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL21298089 0.86 ALDH1A1 (0.46) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL13205973 0.85 ALDH1A1 (0.38) ALDH1A1KDM4ENCOA3HTTLMNA
SCHEMBL21298083 0.84 CA1 (0.52) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL21298078 0.84 CA1 (0.52) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL21297902 0.84 KDM4E (0.40) CA1CA2ALDH1A1KDM4EGAA
SCHEMBL13206092 0.83 ALDH1A1 (0.35) ALDH1A1KDM4EMAPTUSP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNIV ARIZONA STATE (US) 2023-06-22 US disclosed
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2021-01-28 US disclosed
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-12-01 US disclosed
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2020-03-05 US disclosed
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CA1 984/4885CA2 1226/4885ALDH1A1 2839/4885
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CA1 984/4885CA2 1226/4885ALDH1A1 2839/4885
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CA1 984/4885CA2 1226/4885ALDH1A1 2839/4885
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials KCNK4, TRPC4, TBRG4 CA1 4338/4885CA2 2217/4885ALDH1A1 566/4885
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials NT5C, HTR3D, IK CA1 3325/4885CA2 2023/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.